S. Haas Et Al. , "Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry," PLOS ONE , vol.11, no.10, 2016
Haas, S. Et Al. 2016. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry. PLOS ONE , vol.11, no.10 .
Haas, S., ten Cate, H., Accetta, G., Angchaisuksiri, P., Bassand, J., Camm, A. J., ... Corbalan, R.(2016). Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry. PLOS ONE , vol.11, no.10.
Haas, Sylvia Et Al. "Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry," PLOS ONE , vol.11, no.10, 2016
Haas, Sylvia Et Al. "Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry." PLOS ONE , vol.11, no.10, 2016
Haas, S. Et Al. (2016) . "Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry." PLOS ONE , vol.11, no.10.
@article{article, author={Sylvia Haas Et Al. }, title={Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry}, journal={PLOS ONE}, year=2016}